Mike Havrilla
Mike Havrilla
Send Message
Mike Havrilla
Stop FollowingMike Havrilla
ABOUT
Mike Havrilla is a clinical IV pharmacist, marathon runner, writer and biotech stock trader with experience that includes licensed pharmacist since January 2004, online investing since August 1997 and writing for investors since April 2007. Mike holds Doctor of Pharmacy and Bachelor of Science (Biology) degrees from the University of Pittsburgh and worked in the pharmaceutical industry for Wyeth prior to pharmacy school. He is also an avid runner (50-75 miles per week) since 1992 and has completed 22 marathons with a personal best time of 2 hours, 54 minutes for the 26.2 mile race.
SNAPSHOT
- Description: Newsletter author. Trading frequency: Weekly
- Interests: Stocks - long
COMPANY
BioRunUp.com BioRunUp.com has evolved into an informed biotech stock trading community seeking to generate consistent profits in any market condition through a variety of long, short and options-based strategies.
BLOG
Twitter @mikehavrilla
Pharmacist. Biotech Stock Trader & Writer. Marathon Runner. Woodsman.
Book
Currently, there are no book details for Mike Havrilla.
LATEST STOCKTALK
more »
Who are the top 50 industry voices in #biotech twittersphere? Our @FierceBiotech report with data from @Appeering http://bit.ly/UMAjPD
Nov 26, 2012
Latest Comments
more »
- CT scan is the gold standar... on Venaxis Poised For Run-Up Into Pivotal Study Re...
- They expect to make initial... on Venaxis Poised For Run-Up Into Pivotal Study Re...
- forgot to embed the six-mon... on Nymox Pharma: Developing A Potential Long-Term ...
- tax loss selling is possibl... on Anika Therapeutics: Growth Stock At Value Price...
- I guess we will find out ne... on Amicus Therapeutics Poised For Rebound Into Dec...
Latest comments on Mike's Articles
- anomaly1 on Venaxis Poised For Run-Up Into Pivotal Study Re...
- in4thelonghaul on Venaxis Poised For Run-Up Into Pivotal Study Re...
- Hussler on Flamel: Near-Term, Under The Radar FDA Catalyst...
- Mike Havrilla on Venaxis Poised For Run-Up Into Pivotal Study Re...
- norroway on Venaxis Poised For Run-Up Into Pivotal Study Re...
LATEST ARTICLES & INSTAPOSTS
more »


